Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Share this article

Protein C as a surrogate end-point for clinical trials of sepsis

Kathleen D Liu and Michael A Matthay*

Critical Care 2008, 12:139 doi:10.1186/cc6859


See related research by Shorr et al, http://ccforum.com/content/12/2/R45

Accesses  

  • Last 30 days: 24 accesses
  • Last 365 days: 334 accesses
  • All time: 1563 accesses

Cited by

BioMed Central: 1 citation

Research   Open Access Highly Accessed

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

Andrew F Shorr, Jonathan M Janes, Antonio Artigas, Jyrki Tenhunen, Duncan LA Wyncoll, Emmanuelle Mercier, Bruno Francois, Jean-Louis Vincent, Burkhard Vangerow, Darell Heiselman, Amy G Leishman, Yajun E Zhu, Konrad Reinhart, Critical Care 2010, 14:R229 (21 December 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations